Q4 2024 ZimVie Inc Earnings Call Transcript
Key Points
- ZimVie Inc (ZIMV) successfully transitioned to a pure-play dental company by selling its Spine business, focusing on dental implants, biomaterials, and digital dentistry solutions.
- The company reported $450 million in full-year revenue for 2024, demonstrating strong financial performance.
- ZimVie Inc (ZIMV) improved adjusted EBITDA margins by over 2 percentage points for the year, showcasing operational efficiency.
- The company generated over $21 million in operating cash flow in the fourth quarter, indicating strong cash management.
- ZimVie Inc (ZIMV) significantly reduced its debt using proceeds from the sale of its Spine business, enhancing financial stability.
- Total third-party net sales for the fourth quarter decreased by 1.4% in reported rates, indicating a decline in sales performance.
- US third-party net sales for the fourth quarter declined by 1.5%, driven by weakness in implant sales and lower oral scanner sales.
- The company experienced softness in its end markets, impacting overall financial performance.
- ZimVie Inc (ZIMV) faced challenges in the implant market, with pressure on more expensive cases and specialist-level procedures.
- The company's guidance for 2025 reflects a potential 1% decline to 2% reported growth, indicating cautious market expectations.
Good afternoon and welcome to ZimVie's fourth-quarter 2024 earnings conference call. (Operator Instructions) As a reminder, this call is being recorded for replay purposes.
I would now like to turn the call over to Marissa Bych from Gilmartin Group for introductory disclosures.
Thank you all for joining today's call. Earlier today, ZimVie released financial results for the quarter and year ended December 31, 2024. A copy of the press release is available on the company's website, zimvie.com, as well as on SEC.gov.
Before we begin, I'd like to remind you that management will make comments during this call that include forward-looking statements. Actual results may differ materially from those indicated by the forward-looking statements due to a variety of risks and uncertainties. Please refer to the company's most recent periodic report filed with the SEC and subsequent SEC filings for a detailed discussion of these risks and uncertainties.
In addition, the discussion on this call will include
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
